Compare · ILMNV vs RVTY
ILMNV vs RVTY
Side-by-side comparison of Illumina Inc. (ILMNV) and Revvity Inc. (RVTY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMNV and RVTY operate in Biotechnology: Laboratory Analytical Instruments (Health Care), so they compete in similar markets.
- RVTY carries a market cap of $16.50B.
- RVTY has hit the wire 8 times in the past 4 weeks while ILMNV has been quiet.
- RVTY has more recent analyst coverage (24 ratings vs 0 for ILMNV).
- Company
- Illumina Inc.
- Revvity Inc.
- Price
- -
- -
- Market cap
- -
- $16.50B
- 1M return
- -
- -2.02%
- 1Y return
- -
- +58.82%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 8
- Recent ratings
- 0
- 24
Latest ILMNV
- SVP, Chief Commercial Officer Cunningham Everett was granted 36,860 shares (SEC Form 4)
- Director Ullem Scott B. was granted 205 shares, increasing direct ownership by 5% to 4,550 units (SEC Form 4)
- Amendment: Illumina Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities
- Amendment: Illumina Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Latest RVTY
- vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
- Revvity Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Revvity to Showcase Strategy for Powering Scientific Intelligence at 2026 Investor Day
- SEC Form 10-Q filed by Revvity Inc.
- Revvity upgraded by CFRA
- Revvity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Revvity Announces Financial Results for the Third Quarter of 2026
- Revvity Board Declares Quarterly Dividend
- Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
- Revvity to Present at Upcoming Investor Conferences